It has been shown that RvE1, acting through the ChemR23 receptor, can attenuate experimental pulmonary hypertension in mice by inhibiting Wnt family member 7A (Wnt7a)/β-catenin signaling [314]. Here, WNT7A is linked to pulmonary arterial hypertension.